[go: up one dir, main page]

BRPI0801858A2 - uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica - Google Patents

uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica

Info

Publication number
BRPI0801858A2
BRPI0801858A2 BRPI0801858-8A BRPI0801858A BRPI0801858A2 BR PI0801858 A2 BRPI0801858 A2 BR PI0801858A2 BR PI0801858 A BRPI0801858 A BR PI0801858A BR PI0801858 A2 BRPI0801858 A2 BR PI0801858A2
Authority
BR
Brazil
Prior art keywords
extract
cell culture
composition
cosmetic
dermatological
Prior art date
Application number
BRPI0801858-8A
Other languages
English (en)
Inventor
Audrey Gueniche
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BRPI0801858A2 publication Critical patent/BRPI0801858A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/983—Blood, e.g. plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

USO DE PELO MENOS UM MEIO DE CULTURA CELULAR CONDICIONADO OU DE SEU EXTRATO E COMPOSIÇçO COSMÉTICA OU DERMATOLàGICA. A presente invenção tem por objeto o uso de pelo menos um meio de cultura celular condicionado ou de seu extrato, para a preparação de uma composição destinada ao tratamento dos sinais de inflamação e/ou desordens imunes, meios esses que são suscetiveis de serem obtidos por contato com pelo menos uma cultura de células do trato digestivo e pelo menos microorganismos probiáticos. A presente invenção também refere-se a composições que contêm um meio condicionado e um agente que possui um efeito colateral irritante.
BRPI0801858-8A 2007-02-26 2008-02-27 uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica BRPI0801858A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0753496A FR2912917B1 (fr) 2007-02-26 2007-02-26 Milieu conditionne et ses utilisations

Publications (1)

Publication Number Publication Date
BRPI0801858A2 true BRPI0801858A2 (pt) 2009-01-13

Family

ID=38658699

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0801858-8A BRPI0801858A2 (pt) 2007-02-26 2008-02-27 uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica

Country Status (6)

Country Link
US (1) US8101167B2 (pt)
EP (1) EP1974719B1 (pt)
CN (1) CN101254213B (pt)
BR (1) BRPI0801858A2 (pt)
ES (1) ES2465671T3 (pt)
FR (1) FR2912917B1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
EP1969120A4 (en) * 2005-12-14 2012-05-30 Organogenesis Inc COMPOSITIONS AND TREATMENTS FOR SKIN CARE
FR2901793B1 (fr) * 2006-05-31 2010-08-27 Oreal Amides hydroxylees comme agents d'hydratation de la peau
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
ES2461791T3 (es) * 2007-09-04 2014-05-21 L'oréal Utilización de una combinación de hesperidina y de un microorganismo para actuar sobre la función de barrera de la piel
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
FR2938429B1 (fr) * 2008-11-19 2012-05-18 Oreal Utilisation cosmetique de microorganisme(s) pour le traitement des desordres du cuir chevelu
ES2677905T3 (es) * 2008-07-29 2018-08-07 L'oreal Uso cosmético y dermatológico de microorganismos probióticos Lactobacillus paracasei para el tratamiento de trastornos grasos del cuero cabelludo
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2937547B1 (fr) * 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
FR2937548B1 (fr) * 2008-10-28 2010-12-31 Oreal Utilisation d'un lysat de bifidobacterium species pour preparer la peau d'un sujet a traitement cutane de surface
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
EP2228067B1 (de) * 2010-02-22 2013-12-11 LR Health & Beauty Systems GmbH Probiotische Zusammensetzung und deren Verwendung
FR2959128B1 (fr) * 2010-04-23 2012-07-13 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
WO2013039374A2 (es) * 2011-09-15 2013-03-21 Zepeda Lopez Hector Manuel Método de extracción, comprobación y conteo de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como tratamiento contra la enfermedad conocida como vitíligo
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
JP6284881B2 (ja) * 2011-10-25 2018-02-28 アーチ・パーソナル・ケアー・プロダクツ・リミテッド・パートナーシップ 連続または同時発酵の抽出物を含有する組成物
US20130269719A1 (en) 2012-04-11 2013-10-17 R.J. Reynolds Tobacco Company Method for treating plants with probiotics
FR2996450B1 (fr) * 2012-10-05 2017-01-13 Oreal Propionibacterium freudenreichii en tant qu'actif contre les desordres cutanes
CN103845276A (zh) * 2012-11-28 2014-06-11 立普生有限公司 细菌视紫红质生物凝胶及其制备方法
FR2999932B1 (fr) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999931A1 (fr) 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
TWI570237B (zh) * 2013-12-02 2017-02-11 麗豐實業股份有限公司 益生菌組合物之用途
US20150174254A1 (en) * 2013-12-23 2015-06-25 Mcneil-Ppc, Inc. Topical gel compositions including polycaprolactone polymer and methods for enhancing the topical application of a benefit agent
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
WO2017035280A1 (en) * 2015-08-24 2017-03-02 Nugene, Inc. Skin damage healing aids and dressings
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
US11684574B2 (en) 2016-06-30 2023-06-27 University of Pittsburgh—of the Commonwealth System of Higher Education Artificial cells and delivery devices for use in tissue engineering, and related methods
EP3746186A1 (en) * 2018-02-02 2020-12-09 Postbiotica S.R.L. Use of a postbiotic-based composition for the treatment of skin diseases
KR101998067B1 (ko) * 2019-03-29 2019-09-27 (주)지에프씨생명과학 비피도박테리움 속 gfc-b09 균주 및 이를 이용하여 제조된 발효물
IL272145A (en) 2020-01-20 2021-07-29 Stem Cell Medicine Ltd Cosmetic compositions with protein concentrate from conditioned medium of adipose-derived stem cells
CN111235058B (zh) * 2020-02-20 2022-11-15 江苏微康生物科技有限公司 一种具有修复紫外损伤、缓解炎症、预防皮肤光老化作用的短双歧杆菌及其制备方法和应用
US20210275612A1 (en) * 2020-03-09 2021-09-09 Glac Biotech Co., Ltd. Method for alleviating inflammation-related disorder
EP4585055A1 (en) 2024-01-12 2025-07-16 Nicoventures Trading Limited Oral product with probiotic component

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85544A1 (fr) 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
LU85849A1 (fr) 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
LU87066A1 (fr) 1987-12-04 1989-07-07 Oreal Association de derives de 1,8-hydroxy et/ou acyloxy anthracen ou anthrone et de derives de pyrimidine pour induire et stimuler la croissance des chevaux et diminuer leur chute
LU87109A1 (fr) 1988-01-20 1989-08-30 Cird Esters et thioesters aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
JPH03119163A (ja) 1989-06-05 1991-05-21 Sequa Chemicals Inc 不織繊維用バインダー
DE852949T1 (de) 1997-03-31 1998-11-19 Shiseido Co Ltd Verwendung von Alpha-Aminosäuren zur Förderung des desmosomalen Abbaues oder der Abschuppung der Hornschicht
GB2365770B (en) * 2000-08-18 2002-07-31 Diomed Dev Ltd Antifungal ketoconazole composition for topical use
JP4510376B2 (ja) * 2000-10-06 2010-07-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 皮膚の免疫系のバランスを保つためのプロバイオティック乳酸菌の使用
CA2452865A1 (en) * 2001-06-07 2002-12-12 Skinmedica, Inc. Conditioned cell culture media and uses thereof
EP1896092A1 (de) 2003-05-24 2008-03-12 JUVENA (International) AG Kosmetische oder dermatologische Zubereitung umfassend eine Nährmedienphase
AU2005212311A1 (en) * 2004-02-06 2005-08-25 The University Of Chicago An anti-inflammatory, cytoprotective factor derivable from a probiotic organism
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles

Also Published As

Publication number Publication date
FR2912917A1 (fr) 2008-08-29
EP1974719A1 (fr) 2008-10-01
US20080206171A1 (en) 2008-08-28
EP1974719B1 (fr) 2014-03-26
ES2465671T3 (es) 2014-06-06
US8101167B2 (en) 2012-01-24
CN101254213A (zh) 2008-09-03
CN101254213B (zh) 2012-10-10
FR2912917B1 (fr) 2012-05-18

Similar Documents

Publication Publication Date Title
BRPI0801858A2 (pt) uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica
BRPI0802049A2 (pt) composiÇço cosmÉtica ou dermatolàgica, usos de pelo menos um meio de cultura celular, processo cosmÉtico para melhorar a homeostase cutÂnea e processo para preparar uma composiÇço cosmÉtica ou dermatolàgica
BR112015001620A2 (pt) composição de meio de cultura, e método para cultivo de célula ou tecido usando-se dita composição
BRPI0516437A (pt) utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
BRPI0916693A2 (pt) uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição cosmética e/ou dermatológica, e, método de tratamento cosmético
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
BR112012001984B8 (pt) anticorpos humanos com alta afinidade para angiopoietina-2 humana, uso dos mesmos e composição farmacêutica
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
ECSP11011297A (es) Proteinas ligadoras il-17
BR112013019258A8 (pt) Uso de uma formulação probiótica compreendendo uma cepa de bifidobacterium bifidum
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
BR112016010803B8 (pt) Suplemento alimentar a base de ácido resínico e uso não terapêutico de um suplemento alimentar a base de ácido resínico
BR112015019066A2 (pt) Anticorpos humanos para proteína f do vírus respiratório sincicial e métodos de uso dos mesmos
BRPI1105245A2 (pt) composições para conferir hidrofobicidade e impermeabilidade ao cabelo
BRPI0700914A (pt) composição cosmética para aplicação tópica, usos da composição e processo de tratamento das matérias queratìnicas
EP2518150A3 (en) 5'Triphosphate oligonucleotide with blunt end and uses thereof
BR112013017021A2 (pt) composição nutricional compreendendo fibra e probióticos para reduzir os sintomas intestinais realacionados ao estresse
WO2014049447A3 (en) A whole, leech saliva extract
UY30172A1 (es) Partículas de fosfato, polifosfato y metafosfato de aluminio, su uso como pigmento en pinturas y método para producir las mismas
CL2011002835A1 (es) Compuestos derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para tratar dolores agudos o cronicos de tipos neurogeno, asociados a enfermedades inflamatorias, entre otros.
BR112014019623A8 (pt) Composição aditiva de condicionamento para o fornecimento benefícios de longa duração e imediatos para substratos de queratina
BR112014031914A2 (pt) cápsula de estradiol solúvel para inserção vaginal
BR112012012476A2 (pt) "composições nutritivas incluindo um componente de alta proteína e nucleotídeos exôgenos"
BR112012012960A2 (pt) supositório para administração retal, vaginal ou uretral e seus usos.
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM ART. 8O COMBINADO COM ART. 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61K 35/12 (2015.01), A61K 8/98 (2006.01), A61K 8/